N🟁N

Bull & Lifshitz, LLP Announces Investigation of EMS Technologies, Inc.

  //science-technology.news-articles.net/content/2 .. unces-investigation-of-ems-technologies-inc.html
  Published in Science and Technology on Tuesday, June 21st 2011 at 7:30 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

NEW YORK--([ BUSINESS WIRE ])--Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of EMS Technologies, Inc. (NASDAQ: ELMG) (referred to as "EMS" or the aCompanya) to Honeywell International Inc. (aHoneywella) in an all-cash transaction valued at approximately $491 million, net of cash acquired.

Under the terms of the agreement, a wholly-owned subsidiary of Honeywell will commence a tender offer within ten business days of June 13, 2011 to purchase all of EMSa™ outstanding shares for $33.00 per share in cash.

Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Companya™s shareholders.

If you are a holder of EMS common stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.

If you are a shareholder of EMS and would like more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (866) 313-6222 or by sending an e-mail including your contact information to: [ counsel@nyclasslaw.com ]. All e-mail correspondence should make reference to EMS.

Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at [ www.nyclasslaw.com ].

ATTORNEY ADVERTISING. © 2011 Bull & Lifshitz, LLP. The law firm responsible for this advertisement is Bull & Lifshitz, LLP, 18 East 41^st Street, New York, New York 10017, (212) 213-6222. Prior results do not guarantee or predict a similar outcome with respect to any future matter.